Evaluating the relationship between biomarkers of potential harm and biomarkers of tobacco exposure among current, past, and nonsmokers: data from the National Health and Nutrition Examination Survey 2007–2012

References

• Abel GA, Hays JT, Decker PA, et al. (2005). Effects of biochemically confirmed smoking cessation on white blood cell count. Mayo Clin Proc 80:1022–8.
   PubMed Web of Science ®Google Scholar
• Albanes D, Jones DY, Micozzi MS, Mattson ME. (1987). Associations between smoking and body weight in the US population: analysis of NHANES II. Am J Public Health 77:439–44.
   PubMed Web of Science ®Google Scholar
• American Lung Association. (2015). Smoking facts. [Online] Available from: http://wwwlungorg/stop-smoking/smoking-facts/ [last accessed 22 Nov 2015].
   Google Scholar
• Barter P. (2011). HDL-C: role as a risk modifier. Atheroscler Suppl 12:267–70.
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Bernert JT, Caraballo RS, et al. (2009). Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol 169:236–48.
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Jacob P. III. (1994). Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther 56:483–93.
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Jacob P. III. (2001). Trans-3'-hydroxycotinine: disposition kinetics, effects and plasma levels during cigarette smoking. Br J Clin Pharmacol 51:53–9.
   PubMed Web of Science ®Google Scholar
• Bevilacqua MP, Pober JS, Wheeler ME Jr., et al. (1985). Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest 76:2003–11.
   PubMed Web of Science ®Google Scholar
• Brandt HC, Watson WP. (2003). Monitoring human occupational and environmental exposures to polycyclic aromatic compounds. Ann Occup Hyg 47:349–78.
   PubMed Web of Science ®Google Scholar
• Brown DW, Giles WH, Croft JB. (2001). White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol 54:316–22.
   PubMed Web of Science ®Google Scholar
• Calapai G, Caputi AP, Mannucci C, et al. (2009). Cardiovascular biomarkers in groups of established smokers after a decade of smoking. Basic Clin Pharmacol Toxicol 104:322–8.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. (2015). National Health and Nutrition Examination Survey Data (NHANES). [Online] Available from: http://wwwcdcgov/nchs/nhaneshtm [last accessed 22 Nov 2015].
   Google Scholar
• Centers for Disease Control and Prevention. (2010). How tobacco smoke causes disease: The biology and behavioral basis for smoking - attributable disease: A Report of the Surgeon General. [Online] Available from: http://www ncbi nlm nih gov/books/NBK53017/ [last accessed 22 Nov 2015].
   Google Scholar
• Charland SL, Malone DC. (2010). Prediction of cardiovascular event risk reduction from lipid changes associated with high potency dyslipidemia therapy. Curr Med Res Opin 26:365–75.
   PubMed Web of Science ®Google Scholar
• Clair C, Bitton A, Meigs JB, Rigotti NA. (2011). Relationships of cotinine and self-reported cigarette smoking with hemoglobin A1c in the US: results from the National Health and Nutrition Examination Survey, 1999-2008. Diabetes Care 34:2250–5.
   PubMed Web of Science ®Google Scholar
• Eliasson B, Hjalmarson A, Kruse E, et al. (2001). Effect of smoking reduction and cessation on cardiovascular risk factors. Nicotine Tob Res 3:249–55.
   PubMedGoogle Scholar
• Forey BA, Fry JS, Lee PN, et al. (2013). The effect of quitting smoking on HDL-cholesterol: a review based on within-subject changes. Biomark Res 1:26.
   PubMedGoogle Scholar
• Forte TM, Subbanagounder G, Berliner JA, et al. (2002). Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice. J Lipid Res 43:477–85.
   PubMed Web of Science ®Google Scholar
• Frost-Pineda K, Liang Q, Liu J, et al. (2011). Biomarkers of potential harm among adult smokers and nonsmokers in the total exposure study. Nicotine Tob Res 13:182–93.
   PubMed Web of Science ®Google Scholar
• Ginsberg G, Hattis D, Sonawane B. (2004). Incorporating pharmacokinetic differences between children and adults in assessing children's risks to environmental toxicants. Toxicol Appl Pharmacol 198:164–83.
   PubMed Web of Science ®Google Scholar
• Gordon T, Kannel WB. (1982). Multiple risk functions for predicting coronary heart disease: the concept, accuracy, and application. Am Heart J 103:1031–9.
   PubMed Web of Science ®Google Scholar
• Graeter LJ, Mortensen ME. (1996). Kids are different: developmental variability in toxicology. Toxicology 111:15–20.
   PubMed Web of Science ®Google Scholar
• Hatsukami DK, Benowitz NL, Rennard SI, et al. (2006). Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine Tob Res 8:600–22.
   PubMed Web of Science ®Google Scholar
• Hecht SS. (2002). Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 23:907–22.
   PubMed Web of Science ®Google Scholar
• Hecht SS, Carmella SG, Chen M, et al. (1999). Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res 59:590–6.
   PubMed Web of Science ®Google Scholar
• Hecht SS, Carmella SG, Murphy SE, et al. (1993). A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. N Engl J Med 329:1543–6.
   PubMed Web of Science ®Google Scholar
• Hessler JR, Robertson AL Jr., Chisolm GM. III. (1979). LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 32:213–29.
   PubMed Web of Science ®Google Scholar
• Hlatky MA, Greenland P, Arnett DK, et al. (2009). Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 119:2408–16.
   PubMed Web of Science ®Google Scholar
• Ind PW. (2005). COPD disease progression and airway inflammation: uncoupled by smoking cessation. Eur Respir J 26:764–6.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine. (2001). Clearing the smoke. In: Stratton K, Shetty P, Wallace R, Bondurant S, eds. Assessing the science base for tobacco harm reduction. Washington, DC: National Academy Press.
   Google Scholar
• International Agency for Research on Cancer. (2010). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Ingested Nitrate and Nitrite, and Cyanobacterial Peptide Toxins. Volume 94. Lyon, France: International Agency for Research on Cancer.
   Google Scholar
• Jain RB. (2015). Serum cotinine and urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanonol levels among non-Hispanic Asian American smokers and nonsmokers as compared to other race/ethnicities: data from NHANES 2011-2012. Chemosphere 120:584–91.
   PubMed Web of Science ®Google Scholar
• Jedrychowski W, Whyatt RM, Cooper TB, et al. (1998). Exposure misclassification error in studies on prenatal effects of tobacco smoking in pregnancy and the birth weight of children. J Expo Anal Environ Epidemiol 8:347–57.
   PubMedGoogle Scholar
• Johnson HM, Gossett LK, Piper ME, et al. (2010a). Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. J Am Coll Cardiol 55:1988–95.
   PubMed Web of Science ®Google Scholar
• Johnson HM, Piper ME, Jorenby DE, et al. (2010b). Risk factors for subclinical carotid atherosclerosis among current smokers. Prev Cardiol 13:166–71.
   PubMedGoogle Scholar
• Jongeneelen FJ. (1994). Biological monitoring of environmental exposure to polycyclic aromatic hydrocarbons; 1-hydroxypyrene in urine of people. Toxicol Lett 72:205–11.
   PubMed Web of Science ®Google Scholar
• Khariwala SS, Scheuermann TS, Berg CJ, et al. (2014). Cotinine and tobacco-specific carcinogen exposure among nondaily smokers in a multiethnic sample. Nicotine Tob Res 16:600–5.
   PubMed Web of Science ®Google Scholar
• Lee G, Walser TC, Dubinett SM. (2009). Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer. Curr Opin Pulm Med 15:303–7.
   PubMed Web of Science ®Google Scholar
• Liu J, Liang Q, Frost-Pineda K, et al. (2011). Relationship between biomarkers of cigarette smoke exposure and biomarkers of inflammation, oxidative stress, and platelet activation in adult cigarette smokers. Cancer Epidemiol Biomarkers Prev 20:1760–9.
   PubMed Web of Science ®Google Scholar
• Lowe FJ, Gregg EO, McEwan M. (2009). Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers. Clin Chem Lab Med 47:311–120.
   PubMed Web of Science ®Google Scholar
• Madsen C, Nafstad P, Eikvar L, et al. (2007). Association between tobacco smoke exposure and levels of C-reactive protein in the Oslo II Study. Eur J Epidemiol 22:311–17.
   PubMed Web of Science ®Google Scholar
• Margolis KL, Manson JE, Greenland P, et al. (2005). Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med 165:500–8.
   PubMed Web of Science ®Google Scholar
• Martinez-Sanchez JM, Ballbe M, Fu M, et al. (2014). Electronic cigarette use among adult population: a cross-sectional study in Barcelona, Spain (2013-2014). BMJ Open 4:e005894.
   PubMed Web of Science ®Google Scholar
• National Institutes of Health (1998). Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults–the evidence report. Obes Res 6 Suppl:51S–209S.
   Google Scholar
• Navab M, Reddy ST, Van Lenten BJ, Fogelman AM. (2011). HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol 8:222–32.
   PubMed Web of Science ®Google Scholar
• O'Connor RJ, Giovino GA, Kozlowski LT, et al. (2006). Changes in nicotine intake and cigarette use over time in two nationally representative cross-sectional samples of smokers. Am J Epidemiol 164:750–9.
   PubMed Web of Science ®Google Scholar
• Pelkonen O, Nebert DW. (1982). Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol Rev 34:189–222.
   PubMed Web of Science ®Google Scholar
• Rodgman A, Smith CJ, Perfetti TA. (2000). The composition of cigarette smoke: a retrospective, with emphasis on polycyclic components. Hum Exp Toxicol 19:573–95.
   PubMed Web of Science ®Google Scholar
• Roethig HJ, Feng S, Liang Q, et al. (2008). A 12-month, randomized, controlled study to evaluate exposure and cardiovascular risk factors in adult smokers switching from conventional cigarettes to a second-generation electrically heated cigarette smoking system. J Clin Pharmacol 48:580–91.
   PubMed Web of Science ®Google Scholar
• Roethig HJ, Munjal S, Feng S, et al. (2009). Population estimates for biomarkers of exposure to cigarette smoke in adult US cigarette smokers. Nicotine Tob Res 11:1216–25.
   PubMed Web of Science ®Google Scholar
• Sarkar M, Kapur S, Frost-Pineda K, et al. (2008). Evaluation of biomarkers of exposure to selected cigarette smoke constituents in adult smokers switched to carbon-filtered cigarettes in short-term and long-term clinical studies. Nicotine Tob Res 10:1761–72.
   PubMed Web of Science ®Google Scholar
• Sarkar M, Liu J, Koval T, et al. (2010). Evaluation of biomarkers of exposure in adult cigarette smokers using Marlboro snus. Nicotine Tob Res 12:105–16.
   PubMed Web of Science ®Google Scholar
• St. Helen G, Goniewicz ML, Dempsey D, et al. (2012). Exposure and kinetics of polycyclic aromatic hydrocarbons (PAHs) in cigarette smokers. Chem Res Toxicol 25:952–64.
   PubMed Web of Science ®Google Scholar
• Strickland P, Kang D. (1999). Urinary 1-hydroxypyrene and other PAH metabolites as biomarkers of exposure to environmental PAH in air particulate matter. Toxicol Lett 108:191–9.
   PubMed Web of Science ®Google Scholar
• Tall AR, Yvan-Charvet L, Terasaka N, et al. (2008). HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metab 7:365–75.
   PubMed Web of Science ®Google Scholar
• Tamakoshi K, Toyoshima H, Yatsuya H, et al. (2007). White blood cell count and risk of all-cause and cardiovascular mortality in nationwide sample of Japanese-results from the NIPPON DATA90. Circ J 71:479–85.
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2007). The Scientific Basis of Tobacco Product Regulation: Report of a WHO Study Group. WHO Technical Report Series. Vol. 945. Geneva: World Health Organization.
   Google Scholar
• Yasue H, Hirai N, Mizuno Y, et al. (2006). Low-grade inflammation, thrombogenicity, and atherogenic lipid profile in cigarette smokers. Circ J 70:8–13.
   PubMed Web of Science ®Google Scholar
• Yuan JM, Butler LM, Gao YT, et al. (2014). Urinary metabolites of a polycyclic aromatic hydrocarbon and volatile organic compounds in relation to lung cancer development in lifelong never smokers in the Shanghai cohort study. Carcinogenesis 35:339–45.
   PubMed Web of Science ®Google Scholar